Skip to main content
padlock icon - secure page this page is secure

Publisher: Wolters Kluwer

Volume 27, Number 1, January 2017

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study
pp. 1-6(6)
Authors: Bousman, Chad A.; Müller, Daniel J.; Ng, Chee H.; Byron, Keith; Berk, Michael; Singh, Ajeet B.

Favourites:
ADD

Genome-wide association study of paliperidone efficacy
pp. 7-18(12)
Authors: Li, Qingqin; Wineinger, Nathan E.; Fu, Dong-Jing; Libiger, Ondrej; Alphs, Larry; Savitz, Adam; Gopal, Srihari; Cohen, Nadine; Schork, Nicholas J.

Favourites:
ADD

The influence of living donor SHROOM3 and ABCB1 genetic variants on renal function after kidney transplantation
pp. 19-26(8)
Authors: Yan, Lin; Li, Yi; Tang, Jiang-Tao; An, Yun-Fei; Luo, Li-Mei; Dai, Bo; Shi, Yun-Ying; Wang, Lan-Lan

Favourites:
ADD

Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese population
pp. 27-38(12)
Authors: Tsamandouras, Nikolaos; Guo, Yingying; Wendling, Thierry; Hall, Stephen; Galetin, Aleksandra; Aarons, Leon

Favourites:
ADD

PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics
pp. 39-42(4)
Authors: Fohner, Alison E.; McDonagh, Ellen M.; Clancy, John P.; Whirl Carrillo, Michelle; Altman, Russ B.; Klein, Teri E.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more